太龙药业(600222.SH)：明日开市起继续停牌

Core Viewpoint - Tailong Pharmaceutical (600222.SH) announced that its controlling shareholder, Tai Rong Chan Investment, is planning a share transfer that may lead to a change in the company's control [1] Group 1 - The controlling shareholder is actively promoting the major matter and negotiating transaction terms with the counterparties [1] - The transaction parties need to fulfill relevant internal approval procedures [1] - The company expects to remain suspended from trading on December 4, 2025, and anticipates that the suspension will not exceed three trading days [1]